Form 4 for IMDX Insight Molecular Diagnostics Inc.

Accepted 2025-02-04 00:00:00 ET · period of report 2025-01-31 · accession 0001493152-25-004871 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2025-02-04	2025-01-31+	IMDX	SMITH PATRICK W	10%	P - Purchase	$2.01	+915	1.80M	+0.1%	+$1,839

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock, no par value	2025-01-31	P	A	890	$2.01	1,795,046	I See footnote	—	—	(F1) The shares of common stock reported herein are directly held by PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015 (the "Trust"). As the trustee of the Trust, the Reporting Person may be deemed to beneficially own the securities held by the Trust.
2	Common	Common Stock, no par value	2025-02-04	P	A	25	$2.02	1,795,071	I See footnote	—	—	(F1) The shares of common stock reported herein are directly held by PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015 (the "Trust"). As the trustee of the Trust, the Reporting Person may be deemed to beneficially own the securities held by the Trust.